Sildenafil improves right ventricular remodelling in monocrotaline-induced rats by decreasing myocardial apoptosis and activating peroxisome proliferator-activated receptors.

OBJECTIVES To assess the effect of sildenafil on monocrotaline-induced right ventricular (RV) remodeling and investigate the possible mechanism. METHODS Rats were subcutaneously injected with monocrotaline to establish an RV remodeling model and then administered sildenafil (25 mg/kg) from days 1 to 28. After 28 days of administration, the RV systolic pressure and the RV hypertrophy index (RVHI) were measured. The morphology of the right ventricle was observed by H&E staining. The ultrastructure of the right ventricle was observed using a transmission electron microscope. The myocardial apoptosis of the right ventricle was evaluated by TUNEL staining. The protein expression of apoptosis-related proteins and PPARs were examined by western blotting. KEY FINDINGS The results indicated that sildenafil decreased the RV systolic pressure and RVHI, and improved the microstructure and ultrastructure of the right ventricle in monocrotaline-induced rats. In addition, sildenafil suppressed myocardial apoptosis and promoted the protein expression of PPARs of the right ventricle in monocrotaline-induced rats. CONCLUSION Sildenafil inhibits RV remodeling in monocrotaline-induced rats, which might be partially mediated by reducing myocardial apoptosis and activating PPARs.

• Publication year

  2021

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2021-03-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jpp/rgaa017PMID 33793805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sildenafil on pulmonary hypertension associated with left heart failure.

  2018cited by this paper
• Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes

  2018cited by this paper
• Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats

  2018cited by this paper
• Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.

  2018cited by this paper
• Right Ventricle Remodeling and Function in Scleroderma Patients

  2018cited by this paper
• The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells

  2018cited by this paper
• Osthole attenuates right ventricular remodeling via decreased myocardial apoptosis and inflammation in monocrotaline‐induced rats

  2018cited by this paper
• COX6B1 relieves hypoxia/reoxygenation injury of neonatal rat cardiomyocytes by regulating mitochondrial function

  2018cited by this paper
• Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers

  2018cited by this paper
• Beneficial Morphofunctional Changes Promoted by Sildenafil in Resistance Vessels in the Angiotensin II-Induced Hypertension Model.

  2018cited by this paper
• PPAR-γ Activation Prevents Septic Cardiac Dysfunction via Inhibition of Apoptosis and Necroptosis

  2017cited by this paper
• PPARγ Alleviates Right Ventricular Failure Secondary to Pulmonary Arterial Hypertension in Rats.

  2017cited by this paper
• Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator.

  2017cited by this paper
• Peroxisome proliferator-activated receptors as therapeutic targets for heart failure.

  2017cited by this paper
• Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis

  2016cited by this paper
• Mitochondrial involvement in myocyte death and heart failure

  2016cited by this paper
• MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells

  2015cited by this paper
• Angiotensin II-Induced Egr-1 Expression is Suppressed by Peroxisome Proliferator- Activated Receptor-γ Ligand 15d-PGJ2 in Macrophages

  2015cited by this paper
• Astragalus polysaccharide suppresses palmitate-induced apoptosis in human cardiac myocytes: the role of Nrf1 and antioxidant response.

  2015cited by this paper
• Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach.

  2015cited by this paper
• Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.

  2015cited by this paper
• Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells

  2015cited by this paper
• Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.

  2014cited by this paper
• Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion.

  2013cited by this paper
• Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system.

  2013cited by this paper
• The Right Ventricle in Health and Disease: Insights into Physiology, Pathophysiology and Diagnostic Management

  2012cited by this paper
• Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.

  2012cited by this paper
• Clofibrate PPAR&agr; Activation Reduces Oxidative Stress and Improves Ultrastructure and Ventricular Hemodynamics in No-flow Myocardial Ischemia

  2012cited by this paper
• Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

  2010cited by this paper
• Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure

  2010cited by this paper
• PPARs as targets for metabolic and cardiovascular diseases.

  2005cited by this paper

• Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight

  2024cites this paper
• Sildenafil prevents right ventricular hypertrophy and improves heart rate variability in rats with pulmonary hypertension secondary to experimental diabetes

  2022cites this paper